newsfilter
← Latest News
FDA Approved Drugs·

Approval of Jakafi Xr, Nda #217180 (Labeling)

Approval Date: 07/20/2026; Drug Name: Jakafi Xr, Nda #217180; Active Ingredients: RUXOLITINIB PHOSPHATE; Company: Incyte Corp; Submission Status: Approval; Submission Classification: Labeling; Application Number: 217180

Company
INCYTE CORP
Keywords
INCYTE CORP